Another Infant Formula Recalled Over Bacterial Contamination Concerns
TUESDAY, Feb. 21, 2023 (HealthDay News) -- Another brand of baby formula is facing a recall. Formula manufacturer Reckitt recalled 145,000 cans of Enfamil ProSobee formula on Monday because of possible cross-contamination with Cronobacter sakazakii bacteria.
The safety issue "was linked to a material from a third party," the company noted. All tests have been negative for the bacteria, but the recall was announced out of an abundance of caution. No illnesses have been reported in connection with the formula. The company said it has taken "all appropriate corrective actions, including no longer sourcing this material from the supplier."
The recall is for 12.9-oz cans of formula manufactured between August and September 2022 with a use-by date of March 1, 2024. The cans have the codes ZL2HZF or ZL2HZZ on the bottom. Cans were shipped throughout the United States, Guam, and Puerto Rico. Customers should throw out these cans if they have them or return them to the stores where they were purchased for a refund. The recall does not affect any other ProSobee or Reckitt products.
Last year, four infants were sickened and two died in three states related to Cronobacter illness. Although all the infants had consumed powdered formula made by Abbott Inc. at its Michigan plant, genetic testing of Cronobacter found by the U.S. Food and Drug Administration at the plant did not match that related to the babies. Still, the Cronobacter found at the Abbott plant triggered a shutdown and a nationwide formula shortage.
Related Posts
Breast Cancer Risk Estimate Models Vary Substantially at Individual Level
FRIDAY, March 3, 2023 (HealthDay News) -- Breast cancer risk estimates for...
¿Podría la clave para luchar contra la COVID-19 encontrarse en las llamas?
MIÉRCOLES, 29 de junio de 2022 (HealthDay News) -- Las llamas son más que unas...
Severe COVID-19 Rates Low With Monoclonal Antibody Therapy During Delta Surge
WEDNESDAY, July 6, 2022 (HealthDay News) -- Real-world data show that the rates...
Few Older Adults Knowledgeable About Aducanumab for Alzheimer Disease
FRIDAY, Feb. 25, 2022 (HealthDay News) -- Older adults are neither knowledgeable...